Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › risedronate

risedronate

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of risedronate

29 trials tracked of risedronate: 20 in phase 3 or 4 and 2 with published results. The most-cited published study has 579 citations.

29Trials tracked
20Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 8 Phase 3 12 Phase 2 3 Other / NA 6
  1. Phase 4 VERtebral Fracture Treatment Comparisons in Osteoporotic Women Completed · 579 cited
  2. Phase 3 Heartland Osteoporosis Prevention Study Completed · 22 cited
  3. Phase 4 A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture Completed
  4. Phase 4 Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis Completed
  5. Phase 4 Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy Completed
  6. Phase 4 Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use Completed
Show 23 more trials
  1. Phase 4 A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. Completed
  2. Phase 4 Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer Completed
  3. Phase 4 Antiepileptic Drugs and Osteoporotic Prevention Trial Completed
  4. Phase 3 Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period Completed
  5. Phase 3 A Study of Monthly Risedronate for Osteoporosis Completed
  6. Phase 3 Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM) Completed
  7. Phase 3 Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis Completed
  8. Phase 3 Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover Completed
  9. Phase 3 Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis Completed
  10. Phase 3 Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis Completed
  11. Phase 3 Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period Completed
  12. Phase 3 Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method Completed
  13. Phase 3 A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis Completed
  14. Phase 3 Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis Completed
  15. Phase 2 Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients. Completed
  16. Phase 2 Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate Completed
  17. Phase 2 Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT Completed
  18. N/A 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets Completed
  19. N/A IGF-1 and Bone Loss in Women With Anorexia Nervosa Completed
  20. N/A Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance - Completed
  21. N/A Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey) Completed
  22. N/A Effects of Bisphosphonates and Nutritional Supplementation After a Hip Fracture Completed
  23. N/A Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) Completed

Showing the 29 most-cited and recently-updated of 29 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
In male osteoporosis, anabolic therapies improved lumbar spine and hip BMD more than antiresorptives at 12 months
Diabetes & Endocrinology Meta-analysis
In male osteoporosis, anabolic therapies improved lumbar spine and hip BMD more than antiresorptives at 12 months Men Get Osteoporosis Too — and Now We Know Which Drugs Win
This Bayesian network meta-analysis evaluated antiresorptive and anabolic pharmacological interventions in men with osteoporosis.
A new analysis of 18 clinical trials finds that bone-building drugs may outperform bone-preserving drugs for men with osteoporosis, especial…
Frontiers Apr 10, 2026